Clinical Trial Update: Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intrathecal thiotepa in combination with trastuzumab for leptomeningeal metastasis from HER2-positive breast cancer, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leptomeningeal Metastasis

Drugs mentioned

• THIOTEPA (THIOTEPA)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Leptomeningeal Metastasis of HER2-positive Breast Cancer | Phase 2 | Status: RECRUITING